Literature DB >> 20937818

Profilin II regulates the exocytosis of kainate glutamate receptors.

Magali Mondin1, Mario Carta, Elisabeth Normand, Christophe Mulle, Françoise Coussen.   

Abstract

The trafficking of ionotropic glutamate receptors to and from synaptic sites is regulated by proteins that interact with their cytoplasmic C-terminal domain. Profilin IIa (PfnIIa), an actin-binding protein expressed in the brain and recruited to synapses in an activity-dependent manner, was shown previously to interact with the C-terminal domain of the GluK2b subunit splice variant of kainate receptors (KARs). Here, we characterize this interaction and examine the role of PfnIIa in the regulation of KAR trafficking. PfnIIa directly and specifically binds to the C-terminal domain of GluK2b through a diproline motif. Expression of PfnIIa in transfected COS-7 cells and in cultured hippocampal neurons from PfnII-deficient mice decreases the level of extracellular of homomeric GluK2b as well as heteromeric GluK2a/GluK2b KARs. Our data suggest a novel mechanism by which PfnIIa exerts a dual role on the trafficking of KARs, by a generic inhibition of clathrin-mediated endocytosis through its interaction with dynamin-1, and by controlling KARs exocytosis through a direct and specific interaction with GluK2b.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937818      PMCID: PMC3000988          DOI: 10.1074/jbc.M110.140442

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Differential trafficking of GluR7 kainate receptor subunit splice variants.

Authors:  Frédéric Jaskolski; Elisabeth Normand; Christophe Mulle; Françoise Coussen
Journal:  J Biol Chem       Date:  2005-04-01       Impact factor: 5.157

2.  An automated method to quantify and visualize colocalized fluorescent signals.

Authors:  Frédéric Jaskolski; Christophe Mulle; Olivier J Manzoni
Journal:  J Neurosci Methods       Date:  2005-07-15       Impact factor: 2.390

3.  Co-assembly of two GluR6 kainate receptor splice variants within a functional protein complex.

Authors:  Françoise Coussen; David Perrais; Frédéric Jaskolski; Shankar Sachidhanandam; Elisabeth Normand; Joel Bockaert; Philippe Marin; Christophe Mulle
Journal:  Neuron       Date:  2005-08-18       Impact factor: 17.173

4.  Vesicular proteins exocytosed and subsequently retrieved by compensatory endocytosis are nonidentical.

Authors:  Martin Wienisch; Jurgen Klingauf
Journal:  Nat Neurosci       Date:  2006-07-16       Impact factor: 24.884

Review 5.  Kainate receptors.

Authors:  Paulo Pinheiro; Christophe Mulle
Journal:  Cell Tissue Res       Date:  2006-07-18       Impact factor: 5.249

6.  Fear conditioning drives profilin into amygdala dendritic spines.

Authors:  Raphael Lamprecht; Claudia R Farb; Sarina M Rodrigues; Joseph E LeDoux
Journal:  Nat Neurosci       Date:  2006-03-19       Impact factor: 24.884

Review 7.  Molecular determinants of kainate receptor trafficking.

Authors:  F Coussen
Journal:  Neuroscience       Date:  2008-02-10       Impact factor: 3.590

8.  Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway.

Authors:  Gregory D Salinas; Leslie A C Blair; Leigh A Needleman; Justina D Gonzales; Ying Chen; Min Li; Jeffrey D Singer; John Marshall
Journal:  J Biol Chem       Date:  2006-10-24       Impact factor: 5.157

9.  Accurate quantification of the mRNA of NMDAR1 splice variants measured by competitive RT-PCR.

Authors:  A Winkler; B Mahal; W Zieglgänsberger; R Spanagel
Journal:  Brain Res Brain Res Protoc       Date:  1999-04

10.  Mouse profilin 2 regulates endocytosis and competes with SH3 ligand binding to dynamin 1.

Authors:  Ralph Gareus; Alessia Di Nardo; Vladimir Rybin; Walter Witke
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

View more
  8 in total

1.  The human submandibular gland: immunohistochemical analysis of SNAREs and cytoskeletal proteins.

Authors:  Mechthild Stoeckelhuber; Elias Q Scherer; Klaus-Peter Janssen; Julia Slotta-Huspenina; Denys J Loeffelbein; Nils H Rohleder; Markus Nieberler; Rafael Hasler; Marco R Kesting
Journal:  J Histochem Cytochem       Date:  2011-11-30       Impact factor: 2.479

2.  Agonist-dependent endocytosis of γ-aminobutyric acid type A (GABAA) receptors revealed by a γ2(R43Q) epilepsy mutation.

Authors:  Severine Chaumont; Caroline André; David Perrais; Eric Boué-Grabot; Antoine Taly; Maurice Garret
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

3.  Kainate receptor post-translational modifications differentially regulate association with 4.1N to control activity-dependent receptor endocytosis.

Authors:  Bryan A Copits; Geoffrey T Swanson
Journal:  J Biol Chem       Date:  2013-02-11       Impact factor: 5.157

Review 4.  Kainate receptors coming of age: milestones of two decades of research.

Authors:  Anis Contractor; Christophe Mulle; Geoffrey T Swanson
Journal:  Trends Neurosci       Date:  2011-01-20       Impact factor: 13.837

5.  Neuronal profilin isoforms are addressed by different signalling pathways.

Authors:  Kai Murk; Nina Wittenmayer; Kristin Michaelsen-Preusse; Thomas Dresbach; Cora-Ann Schoenenberger; Martin Korte; Brigitte M Jockusch; Martin Rothkegel
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

Review 6.  Trafficking of kainate receptors.

Authors:  Steffen Pahl; Daniel Tapken; Simon C Haering; Michael Hollmann
Journal:  Membranes (Basel)       Date:  2014-08-20

7.  Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis.

Authors:  Urša Pečar Fonović; Janko Kos
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

8.  Integrated miRNA-/mRNA-Seq of the Habenulo-Interpeduncular Circuit During Acute Nicotine Withdrawal.

Authors:  Alison P Casserly; Junko Tsuji; Rubing Zhao-Shea; Ciearra B Smith; Susanna Molas; Andrew R Tapper; Zhiping Weng; Paul D Gardner
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.